血清miR-184、miR-513c-5p表达与复发性流产相关性研究及临床意义

王纪元 ,  郭战坤 ,  张雪 ,  杨欣 ,  李静 ,  索青霞 ,  边冰溪

中国妇幼健康研究 ›› 2024, Vol. 35 ›› Issue (7) : 96 -101.

PDF (1702KB)
中国妇幼健康研究 ›› 2024, Vol. 35 ›› Issue (7) : 96 -101. DOI: 10.3969/j.issn.1673-5293.2024.07.016
临床研究

血清miR-184、miR-513c-5p表达与复发性流产相关性研究及临床意义

作者信息 +

Correlation study and clinical significance of serum miR-184 and miR-513c-5p expressions with recurrent spontaneous abortion

Author information +
文章历史 +
PDF (1742K)

摘要

目的 研究血清微小RNA-184(miR-184)、微小RNA-513c-5p(miR-513c-5p)表达与复发性流产(RSA)相关性及临床意义.方法 选取2019年3月至2022年7月我院收治的67例RSA患者(RSA组)及67例正常早孕期女性(对照组),比较两组、RSA组血清miR-184、miR-513c-5p表达,将RSA组根据妊娠结局分为再次流产与未再次流产亚组,比较两亚组血清miR-184、miR-513c-5p表达.依次运用Pearson、受试者工作特征(ROC)曲线、临床决策分析曲线(DCA)、比值比(OR)进行相关性、预测效能、临床效用、危险度分析.结果 RSA组妊娠前、后血清miR-184、miR-513c-5p均高于对照组,且RSA组妊娠后高于妊娠前(P<0.05);RSA组再次流产患者妊娠后血清miR-184、miR-513c-5p高于未再次流产患者(P<0.05).RSA组妊娠前、后血清miR-184均与miR-513c-5p呈显著正相关(r=0.800、0.750,P<0.001);血清miR-184+miR-513c-5p表达预测RSA再发流产的ROC曲线下面积(AUC)为0.901,高于单独的血清miR-184、miR-513c-5p(Z=3.892、3.411,P<0.05).采用该预测方案进行预测和干预,具有良好的临床效用.妊娠后血清miR-184高表达RSA患者再发流产的风险是低表达患者的7.407倍,血清miR-513c-5p高表达RSA患者再发流产的风险是低表达患者的18.125倍(P<0.05).结论 血清miR-184、miR-513c-5p的高表达与RSA及其再妊娠结局有关,联合检测两者可为再妊娠结局的预测提供一定参考,从而指导做出进一步的决策与治疗.

Abstract

Objective To study the correlation and clinical significance of serum microRNA-184 (miR-184) and microRNA-513c-5p (miR-513c-5p) expression with recurrent spontaneous abortion (RSA). Methods We selected 67 RSA patients (RSA group) and 67 normal early pregnancy women (control group) treated in our hospital from March 2019 to July 2022. The serum expression of miR-184 and miR-513c-5p was compared between the two groups and within the RSA group. The RSA group was divided into two subgroups based on pregnancy outcomes: recurrent abortion and no recurrent abortion. Serum miR-184 and miR-513c-5p expression was compared between two subgroups. Pearson correlation, receiver operating characteristic (ROC) curve, clinical decision analysis (DCA), and odds ratio (OR) were used for correlation, predictive performance, clinical utility, and risk analysis. Results Serum miR-184 and miR-513c-5p levels in the RSA group before and after pregnancy were higher than those in the control group, and post-pregnancy levels were higher than pre-pregnancy levels in the RSA group (P<0.05). Post-pregnancy serum miR-184 and miR-513c-5p levels were higher in recurrent abortion patients than in non-recurrent abortion patients within the RSA group (P<0.05). Pre- and post-pregnancy serum miR-184 levels were significantly positively correlated with miR-513c-5p levels in the RSA group (r=0.800, 0.750, P<0.001). The area under the ROC curve (AUC) for predicting recurrent abortion in RSA patients using combined serum miR-184 and miR-513c-5p expression was 0.901, higher than that using either serum miR-184 or miR-513c-5p alone (Z=3.892, 3.411, P<0.05). This predictive scheme showed good clinical utility for prediction and intervention. The risk of recurrent abortion in RSA patients with high post-pregnancy serum miR-184 expression was 7.407 times higher, and with high serum miR-513c-5p expression was 18.125 times higher than in patients with low expression (P<0.05). Conclusion High expression of serum miR-184 and miR-513c-5p is related to RSA and its subsequent pregnancy outcomes. Combined detection of these markers can provide a reference for predicting subsequent pregnancy outcomes, guiding further decision-making and treatment.

关键词

miR-184 / miR-513c-5p / 复发性流产 / 相关性 / 临床意义

Key words

miR-184 / miR-513c-5p / recurrent spontaneous abortion / correlation / clinical significance

引用本文

引用格式 ▾
王纪元,郭战坤,张雪,杨欣,李静,索青霞,边冰溪. 血清miR-184、miR-513c-5p表达与复发性流产相关性研究及临床意义[J]. 中国妇幼健康研究, 2024, 35(7): 96-101 DOI:10.3969/j.issn.1673-5293.2024.07.016

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

Deng T, Liao X, Zhu S. Recent advances in treatment of recurrent spontaneous abortion[J]. Obstet Gynecol Surv, 2022, 77(6): 355-366.

[2]

Liu Z, Sun S, Xu H, et al. Prognostic analysis of antibody typing and treatment for antiphospholipid syndrome-related recurrent spontaneous abortion[J]. Int J Gynaecol Obstet, 2022, 156(1): 107-111.

[3]

Srivastava P, Bamba C, Chopra S, et al. Role of miRNA polymorphism in recurrent pregnancy loss: a systematic review and meta-analysis[J]. Biomark Med, 2022, 16(2): 101-115.

[4]

Ezat SA, Haji AI. Study of association between different microRNA variants and the risk of idiopathic recurrent pregnancy loss[J]. Arch Gynecol Obstet, 2022, 306(4): 1281-1286.

[5]

Wang Y, Cheng Q, Xia Z, et al. Whole-transcriptome sequencing identifies key mRNAs, miRNAs, lncRNAs, and circRNAs associated with unexplained recurrent pregnancy loss[J]. Cell Tissue Res, 2022, 389(1): 129-143.

[6]

Zhang Y, Zhou J, Li M Q, et al. MicroRNA-184 promotes apoptosis of trophoblast cells via targeting WIG1 and induces early spontaneous abortion[J]. Cell Death Dis, 2019, 10(3): 223.

[7]

Wu P, Kong Y, Dai Z, et al. The circular RNA circ-CRIM1 inhibits osteosarcoma progression through sponging miR-513[J]. Mamm Genome, 2021, 32(6): 495-502.

[8]

中华医学会妇产科学分会产科学组. 复发性流产诊治的专家共识[J]. 中华妇产科杂志, 2016, 51(1): 3-9.

[9]

Liu H, Huang X, Mor G, et al. Epigenetic modifications working in the decidualization and endometrial receptivity[J]. Cell Mol Life Sci, 2020, 77(11): 2091-2101.

[10]

Hu K L, Zhang D, Li R. Endometrium preparation and perinatal outcomes in women undergoing single-blastocyst transfer in frozen cycles[J]. Fertil Steril, 2021, 115(6): 1487-1494.

[11]

Diniz-da-Costa M, Kong CS, Fishwick KJ, et al. Characterization of highly proliferative decidual precursor cells during the window of implantation in human endometrium[J]. Stem Cells, 2021, 39(8): 1067-1080.

[12]

寻志杰, 高翔, 韩静. 经阴道彩超对不孕症患者子宫内膜容受性、血流动力学的评估及对IVF-ET妊娠结局的预测价值[J]. 中国妇幼健康研究, 2022, 33(2): 50-55.

[13]

Cui J, Liu X, Yang L, et al. MiR-184 combined with STC2 promotes endometrial epithelial cell apoptosis in dairy goats via RAS/RAF/MEK/ERK pathway[J]. Genes (Basel), 2020, 11(9): 1052.

[14]

Iovino N, Pane A, Gaul U. MiR-184 has multiple roles in drosophila female germline development[J]. Dev Cell, 2009, 17(1): 123-133.

[15]

Rehal A, Benkő Z, De Paco Matallana C, et al. Early vaginal progesterone versus placebo in twin pregnancies for the prevention of spontaneous preterm birth: a randomized, double-blind trial[J]. Am J Obstet Gynecol, 2021, 224(1): 86.e1-86.e19.

[16]

Yan Y, Chen Z, Yang Y, et al. Efficacy of progesterone on threatened miscarriage: an updated meta-analysis of randomized trials[J]. Arch Gynecol Obstet, 2021, 303(1): 27-36.

[17]

Shen SY, Chen Q Z, Zhang LF, et al. Association between serum progesterone concentration in early pregnancy and duration of pregnancy: a cohort study[J]. J Matern Fetal Neonatal Med, 2020, 33(12): 2096-2102.

[18]

Muti P, Donzelli S, Sacconi A, et al. MiRNA-513a-5p inhibits progesterone receptor expression and constitutes a risk factor for breast cancer: the hormone and diet in the etiology of breast cancer prospective study[J]. Carcinogenesis, 2018, 39(2): 98-108.

[19]

尹红, 魏然, 张振, 等. 原因不明复发性自然流产患者血清IL-10水平变化及其与miR-513c-5p的调控关系[J]. 山东医药, 2021, 61(2): 30-34.

AI Summary AI Mindmap
PDF (1702KB)

38

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉